AIMT
TD Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-100,776
| Closed | -$1.68M | – | 1424 |
|
|
2020
Q2 | $1.68M | Buy |
100,776
+2,800
| +3% | +$46.8K | ﹤0.01% | 920 |
|
|
2020
Q1 | $1.41M | Sell |
97,976
-12,100
| -11% | -$175K | ﹤0.01% | 908 |
|
|
2019
Q4 | $3.68M | Buy |
110,076
+7,700
| +8% | +$258K | 0.01% | 785 |
|
|
2019
Q3 | $2.14M | Buy |
102,376
+2,300
| +2% | +$48.2K | ﹤0.01% | 896 |
|
|
2019
Q2 | $2.08M | Buy |
100,076
+5,400
| +6% | +$112K | ﹤0.01% | 898 |
|
|
2019
Q1 | $2.12M | Sell |
94,676
-3,200
| -3% | -$71.5K | ﹤0.01% | 890 |
|
|
2018
Q4 | $2.34M | Sell |
97,876
-151
| -0.2% | -$3.61K | ﹤0.01% | 876 |
|
|
2018
Q3 | $2.67M | Buy |
98,027
+9,100
| +10% | +$248K | ﹤0.01% | 925 |
|
|
2018
Q2 | $2.39M | Buy |
88,927
+2,100
| +2% | +$56.5K | ﹤0.01% | 906 |
|
|
2018
Q1 | $2.76M | Buy |
86,827
+26,124
| +43% | +$832K | ﹤0.01% | 819 |
|
|
2017
Q4 | $2.3M | Buy |
60,703
+23,025
| +61% | +$871K | ﹤0.01% | 852 |
|
|
2017
Q3 | $934K | Sell |
37,678
-400
| -1% | -$9.92K | ﹤0.01% | 1050 |
|
|
2017
Q2 | $783K | Buy |
38,078
+6,400
| +20% | +$132K | ﹤0.01% | 1102 |
|
|
2017
Q1 | $688K | Sell |
31,678
-400
| -1% | -$8.69K | ﹤0.01% | 1133 |
|
|
2016
Q4 | $656K | Buy |
32,078
+600
| +2% | +$12.3K | ﹤0.01% | 1122 |
|
|
2016
Q3 | $472K | Buy |
31,478
+18,178
| +137% | +$273K | ﹤0.01% | 1198 |
|
|
2016
Q2 | $144K | Hold |
13,300
| – | – | ﹤0.01% | 1352 |
|
|
2016
Q1 | $180K | Sell |
13,300
-1,000
| -7% | -$13.5K | ﹤0.01% | 1317 |
|
|
2015
Q4 | $264K | Buy |
+14,300
| New | +$264K | ﹤0.01% | 1265 |
|